NO119948B - - Google Patents
Download PDFInfo
- Publication number
- NO119948B NO119948B NO160436A NO16043665A NO119948B NO 119948 B NO119948 B NO 119948B NO 160436 A NO160436 A NO 160436A NO 16043665 A NO16043665 A NO 16043665A NO 119948 B NO119948 B NO 119948B
- Authority
- NO
- Norway
- Prior art keywords
- pyrimidine
- diamino
- solution
- melting point
- acetylbromothymine
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 23
- -1 zinc halide Chemical class 0.000 claims description 19
- YEDMLMOMWHPBCZ-UHFFFAOYSA-N 5-(1-bromo-2-oxopropyl)-1H-pyrimidine-2,4-dione Chemical compound C(C)(=O)C(C=1C(NC(NC=1)=O)=O)Br YEDMLMOMWHPBCZ-UHFFFAOYSA-N 0.000 claims description 14
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 13
- 239000007795 chemical reaction product Substances 0.000 claims description 9
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 229910021529 ammonia Inorganic materials 0.000 claims description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- YBXJEAPQVULNKE-UHFFFAOYSA-N 1-acetyl-5-methylpyrimidine-2,4-dione Chemical compound CC(=O)N1C=C(C)C(=O)NC1=O YBXJEAPQVULNKE-UHFFFAOYSA-N 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 5
- 229910052753 mercury Inorganic materials 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- OOLOAWZLPBDRJQ-UHFFFAOYSA-N 2-benzylpyrimidine Chemical class N=1C=CC=NC=1CC1=CC=CC=C1 OOLOAWZLPBDRJQ-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000012320 chlorinating reagent Substances 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 57
- 239000000243 solution Substances 0.000 description 40
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 32
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 31
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 23
- 238000002844 melting Methods 0.000 description 22
- 230000008018 melting Effects 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 15
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 14
- 238000003756 stirring Methods 0.000 description 13
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 229940035893 uracil Drugs 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 238000001704 evaporation Methods 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 9
- 238000010992 reflux Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 8
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 8
- KEEYRKYKLYARHO-UHFFFAOYSA-N 5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine Chemical compound C1=C(OC)C(OC)=CC(C)=C1CC1=CN=C(N)N=C1N KEEYRKYKLYARHO-UHFFFAOYSA-N 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 239000005457 ice water Substances 0.000 description 7
- 229960002523 mercuric chloride Drugs 0.000 description 7
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 229940124530 sulfonamide Drugs 0.000 description 6
- 150000003456 sulfonamides Chemical class 0.000 description 6
- 208000003495 Coccidiosis Diseases 0.000 description 5
- 206010023076 Isosporiasis Diseases 0.000 description 5
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 5
- 239000003610 charcoal Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 244000144977 poultry Species 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 235000009518 sodium iodide Nutrition 0.000 description 5
- GWHJZXXIDMPWGX-UHFFFAOYSA-N 1,2,4-trimethylbenzene Chemical compound CC1=CC=C(C)C(C)=C1 GWHJZXXIDMPWGX-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 230000007717 exclusion Effects 0.000 description 4
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 description 4
- 229960000973 sulfadimethoxine Drugs 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- PBKONEOXTCPAFI-UHFFFAOYSA-N 1,2,4-trichlorobenzene Chemical compound ClC1=CC=C(Cl)C(Cl)=C1 PBKONEOXTCPAFI-UHFFFAOYSA-N 0.000 description 3
- IEAAAQXTROJCRL-UHFFFAOYSA-N 5-[(2,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound COC1=CC(OC)=C(OC)C=C1CC1=CN=C(N)N=C1N IEAAAQXTROJCRL-UHFFFAOYSA-N 0.000 description 3
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 230000002140 halogenating effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229960000654 sulfafurazole Drugs 0.000 description 3
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- CRUILBNAQILVHZ-UHFFFAOYSA-N 1,2,3-trimethoxybenzene Chemical compound COC1=CC=CC(OC)=C1OC CRUILBNAQILVHZ-UHFFFAOYSA-N 0.000 description 2
- GYPMBQZAVBFUIZ-UHFFFAOYSA-N 1,2-dimethoxy-4-methylbenzene Chemical compound COC1=CC=C(C)C=C1OC GYPMBQZAVBFUIZ-UHFFFAOYSA-N 0.000 description 2
- NHZLNPMOSADWGC-UHFFFAOYSA-N 4-amino-N-(2-quinoxalinyl)benzenesulfonamide Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CN=C(C=CC=C2)C2=N1 NHZLNPMOSADWGC-UHFFFAOYSA-N 0.000 description 2
- VGDDISWEMMUAON-UHFFFAOYSA-N 5-[(2-ethyl-4,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound CCC1=CC(OC)=C(OC)C=C1CC1=CN=C(N)N=C1N VGDDISWEMMUAON-UHFFFAOYSA-N 0.000 description 2
- NPYPQKXJJZZSAX-UHFFFAOYSA-N 5-benzylpyrimidine Chemical class C=1N=CN=CC=1CC1=CC=CC=C1 NPYPQKXJJZZSAX-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000006178 methyl benzyl group Chemical group 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 229960005404 sulfamethoxazole Drugs 0.000 description 2
- 229960003097 sulfaquinoxaline Drugs 0.000 description 2
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- RELMFMZEBKVZJC-UHFFFAOYSA-N 1,2,3-trichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1Cl RELMFMZEBKVZJC-UHFFFAOYSA-N 0.000 description 1
- OGFAWKRXZLGJSK-UHFFFAOYSA-N 1-(2,4-dihydroxyphenyl)-2-(4-nitrophenyl)ethanone Chemical compound OC1=CC(O)=CC=C1C(=O)CC1=CC=C([N+]([O-])=O)C=C1 OGFAWKRXZLGJSK-UHFFFAOYSA-N 0.000 description 1
- BLMBNEVGYRXFNA-UHFFFAOYSA-N 1-methoxy-2,3-dimethylbenzene Chemical compound COC1=CC=CC(C)=C1C BLMBNEVGYRXFNA-UHFFFAOYSA-N 0.000 description 1
- OEOHCDCMVZIWGN-UHFFFAOYSA-N 2,4-dichloro-5-[(2,4,5-trichlorophenyl)methyl]pyrimidine Chemical compound ClC1=NC=C(C(=N1)Cl)CC1=C(C=C(C(=C1)Cl)Cl)Cl OEOHCDCMVZIWGN-UHFFFAOYSA-N 0.000 description 1
- CQODZDHHCXMCFB-UHFFFAOYSA-N 2,4-dichloro-5-[(2,4,5-trimethoxyphenyl)methyl]pyrimidine Chemical compound ClC1=NC=C(C(=N1)Cl)CC1=C(C=C(C(=C1)OC)OC)OC CQODZDHHCXMCFB-UHFFFAOYSA-N 0.000 description 1
- ZCCDLKYRNJDKFW-UHFFFAOYSA-N 2,4-dichloro-5-[(2-ethyl-4,5-dimethoxyphenyl)methyl]pyrimidine Chemical compound CCC1=CC(OC)=C(OC)C=C1CC1=CN=C(Cl)N=C1Cl ZCCDLKYRNJDKFW-UHFFFAOYSA-N 0.000 description 1
- QMIXFVHSORWJLW-UHFFFAOYSA-N 2,4-dichloro-5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine Chemical compound ClC1=NC=C(C(=N1)Cl)CC1=C(C=C(C(=C1)OC)OC)C QMIXFVHSORWJLW-UHFFFAOYSA-N 0.000 description 1
- SJZAUIVYZWPNAS-UHFFFAOYSA-N 2-methoxy-1,4-dimethylbenzene Chemical compound COC1=CC(C)=CC=C1C SJZAUIVYZWPNAS-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical class OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- NEBQMYHKOREVAL-UHFFFAOYSA-N 4-ethyl-1,2-dimethoxybenzene Chemical compound CCC1=CC=C(OC)C(OC)=C1 NEBQMYHKOREVAL-UHFFFAOYSA-N 0.000 description 1
- CXEXLHAECBWYLX-UHFFFAOYSA-N 5-[(2,4,5-trimethoxyphenyl)methyl]-1H-pyrimidine-2,4-dione Chemical compound COC1=C(CC=2C(NC(NC2)=O)=O)C=C(C(=C1)OC)OC CXEXLHAECBWYLX-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- VNDYJBBGRKZCSX-UHFFFAOYSA-L Zinc bromide Inorganic materials Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 1
- BHHYHSUAOQUXJK-UHFFFAOYSA-L Zinc fluoride Inorganic materials F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- KQNZLOUWXSAZGD-UHFFFAOYSA-N benzylperoxymethylbenzene Chemical compound C=1C=CC=CC=1COOCC1=CC=CC=C1 KQNZLOUWXSAZGD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004490 capsule suspension Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical class CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- DGPIGKCOQYBCJH-UHFFFAOYSA-M sodium;acetic acid;hydroxide Chemical compound O.[Na+].CC([O-])=O DGPIGKCOQYBCJH-UHFFFAOYSA-M 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000001701 trimethoxybenzyl group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41071064A | 1964-11-12 | 1964-11-12 | |
| US41079364A | 1964-11-12 | 1964-11-12 | |
| US45416865A | 1965-05-07 | 1965-05-07 | |
| US45417265A | 1965-05-07 | 1965-05-07 | |
| US46083465A | 1965-06-02 | 1965-06-02 | |
| US470917A US3341541A (en) | 1964-11-12 | 1965-07-09 | Processes and intermediates for pyrimidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO119948B true NO119948B (pl) | 1970-08-03 |
Family
ID=27559952
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO160436A NO119948B (pl) | 1964-11-12 | 1965-11-11 | |
| NO160437A NO115741B (pl) | 1964-11-12 | 1965-11-11 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO160437A NO115741B (pl) | 1964-11-12 | 1965-11-11 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US3485840A (pl) |
| BE (3) | BE671981A (pl) |
| BR (3) | BR6574670D0 (pl) |
| CH (2) | CH467784A (pl) |
| DE (2) | DE1545966A1 (pl) |
| DK (2) | DK125553B (pl) |
| FI (1) | FI43251B (pl) |
| FR (1) | FR5411M (pl) |
| GB (7) | GB1132084A (pl) |
| IL (7) | IL24497A (pl) |
| IT (1) | IT1058251B (pl) |
| MY (2) | MY6700159A (pl) |
| NL (3) | NL6514178A (pl) |
| NO (2) | NO119948B (pl) |
| SE (4) | SE326185B (pl) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3485840A (en) * | 1964-11-12 | 1969-12-23 | Hoffmann La Roche | 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes |
| GB1142654A (en) * | 1965-10-28 | 1969-02-12 | Wellcome Found | Cyano-acetals and their use in benzylpyrimidine synthesis |
| US3515783A (en) * | 1967-10-20 | 1970-06-02 | Hoffmann La Roche | Antibacterial composition containing 5-methyl - 3 - sulfanilamidoisoxazole and trimethoxybenzyl pyrimidine |
| DE2065367C2 (de) * | 1969-03-06 | 1985-04-04 | The Wellcome Foundation Ltd., London | Verfahren zur Herstellung von 2,4- Diamino-5-benzylpyrimidinen |
| GB1261455A (en) * | 1969-03-06 | 1972-01-26 | Burroughs Wellcome Co | Improvements in or relating to substituted acrylonitriles |
| CH513181A (de) * | 1969-06-12 | 1971-09-30 | Hoffmann La Roche | Verfahren zur Herstellung von N-Oxyden von Benzylpyrimidinen |
| US3996356A (en) * | 1969-07-02 | 1976-12-07 | Hoffmann-La Roche Inc. | Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine |
| US3692787A (en) * | 1970-02-16 | 1972-09-19 | Burroughs Wellcome Co | Substituted 2,4-diamino-5-benzyl pyrimidines |
| US3684810A (en) * | 1970-03-11 | 1972-08-15 | Hoffmann La Roche | Process for 2,4-diamino-5-(3,5-dimethoxy-4-hydroxybenzyl) pyrimidine |
| US3993761A (en) * | 1971-12-01 | 1976-11-23 | Hoffmann-La Roche Inc. | Antibacterial compositions |
| BE792096A (fr) * | 1971-12-01 | 1973-05-30 | Hoffmann La Roche | Nouvelles benzylpyrimidines |
| BE795023A (fr) * | 1972-02-07 | 1973-08-06 | Hoffmann La Roche | Nouvelles benzylpyrimidines |
| IT1044231B (it) * | 1972-03-16 | 1980-03-20 | Hoffmann La Roche | Combinazione di sostanze attive utile per combattere infezioni da batteri gram positivi e gran negativi |
| DE2342213C3 (de) * | 1972-10-12 | 1979-10-18 | F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) | Verwendung von potenzierten SuIf onamiden bei der Behandlung oder Verhinderung von Fischinfektionen |
| ZA738760B (en) * | 1972-12-21 | 1974-08-28 | Hoffmann La Roche | Process for the manufacture of benzyl pyrimidines |
| US4143227A (en) * | 1973-02-26 | 1979-03-06 | Hoffmann-La Roche Inc. | Process for substituted 5-benzyl-2,4-diamino-pyrimidines |
| US3931181A (en) * | 1973-07-27 | 1976-01-06 | Hoffmann-La Roche Inc. | 2,4-Diamino-5-benzylpyrimidines |
| CH591456A5 (pl) * | 1973-09-12 | 1977-09-15 | Hoffmann La Roche | |
| US4076810A (en) * | 1973-11-08 | 1978-02-28 | Hoffmann-La Roche Inc. | Benzylpyrimidine antibacterial composition |
| DK136470B (da) * | 1973-11-08 | 1977-10-17 | Hoffmann La Roche | Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidinderivater eller salte deraf. |
| CH591457A5 (pl) * | 1973-11-08 | 1977-09-15 | Hoffmann La Roche | |
| US4033962A (en) * | 1975-06-26 | 1977-07-05 | Hoffman-La Roche Inc. | 2,4-Diamino-pyrimidine derivatives and processes |
| NL7609171A (nl) * | 1975-08-29 | 1977-03-02 | Hoffmann La Roche | Werkwijze voor het bereiden van antibacte- riele middelen. |
| GB1582245A (en) * | 1976-06-09 | 1981-01-07 | Wellcome Found | Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives |
| DE2635765C3 (de) * | 1976-08-09 | 1979-02-08 | Ludwig Heumann & Co Gmbh, 8500 Nuernberg | Verfahren zur Herstellung von 2,4-EMamino-5-(3',4'r5'-trimethoxybenzyl)-pyrimidin |
| LU77364A1 (pl) * | 1977-05-18 | 1979-01-19 | ||
| JPS55102517A (en) * | 1979-01-30 | 1980-08-05 | Shionogi & Co Ltd | Preparation of sulfamethoxazole-trimethoprim complex for administration via body cavity |
| DE2944145A1 (de) * | 1979-11-02 | 1981-05-14 | Dynamit Nobel Ag, 5210 Troisdorf | Verfahren zur herstellung von 2,4-diaminopyrimidin |
| JPS57109713A (en) * | 1980-12-26 | 1982-07-08 | Shionogi & Co Ltd | Pharmaceutical preparation of combined agent of sulfamethoxazole and trimethoprim for medication through celom |
| IT1138146B (it) * | 1981-08-11 | 1986-09-17 | Proter Spa | Processo per la produzione della 2,4-diammino-(3,5-dimetossi-4-metos sietossi-benzil)-pirimidina |
| FI64427C (fi) * | 1982-05-13 | 1989-11-08 | Uponor Nv | Lattiakaivo tai muu kuppimainen vesilukko. |
| HU197670B (en) * | 1986-02-28 | 1989-05-29 | Egyt Gyogyszervegyeszeti Gyar | Process for producing composition comprising 2,4-diamino-5-(3,4-dimethoxybenzyl)-pyrimidine or pharmaceutically suitable acid addition salt thereof as active ingredient |
| FR2595697B1 (fr) * | 1986-03-13 | 1988-07-08 | Rousselot Cie | Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant |
| US4857651A (en) * | 1987-07-29 | 1989-08-15 | American Cyanamid Company | α-(2,3-Di(C1 -C4 alkoxy)ethylamino)-β-cyanostyrene and β-nitrostyrene compounds useful as intermediates in the preparation of insecticidal, acaricidal and nematicidal arylpyrroles and method for the preparation thereof |
| US4996198A (en) * | 1988-07-11 | 1991-02-26 | Hoffmann-La Roche Inc. | Anticoccidial composition |
| US5135924A (en) * | 1989-01-03 | 1992-08-04 | Hoffmann-La Roche Inc. | Therapeutic treatment of animals with oral administration of ormetoprim-potentiated sulfonamides |
| US5158979A (en) * | 1989-04-19 | 1992-10-27 | New York University | Method and compositions for treating pneumocystic carini infections |
| US5258373A (en) * | 1991-07-17 | 1993-11-02 | Hoffmann-La Roche Inc. | Anticoccidial compositions |
| DE4333688C2 (de) * | 1993-10-02 | 2003-11-06 | Guenter Ege | Verfahren zur Herstellung von 3-Aryl-2-(dialkoxymethyl)-propannitrilen und ihre Umsetzung zu 5-Arylmethyl-2,4-diamino-pyrimidinen, insbesondere zu Trimethoprim |
| US5514681A (en) * | 1994-08-17 | 1996-05-07 | Virginia Tech Intellectual Properties, Inc. | Compositions and methods for controlling pest insects |
| TW438796B (en) * | 1996-05-15 | 2001-06-07 | Hoffmann La Roche | 2,4-diaminopyrimidine derivatives, the manufacture process thereof, and the antibiotically-active pharmaceutical composition containing the same |
| US20090162858A1 (en) * | 2007-09-18 | 2009-06-25 | Cornish Virginia W | Orthogonal chemical inducer of dimerization |
| MY146947A (en) * | 2007-10-29 | 2012-10-15 | Nippon Suisan Kaisha Ltd | Antiparasitic agent for fish and method of controlling proliferation of fish parasites |
| TWI429397B (zh) * | 2009-04-27 | 2014-03-11 | Nippon Suisan Kaisha Ltd | 含有葉酸合成抑制劑及/或葉酸活性化抑制劑之組成物的用途 |
| FR3049861A1 (fr) | 2016-04-07 | 2017-10-13 | Univ Claude Bernard Lyon | Nouvelles compositions antivirales pour le traitement de la grippe |
| CN106083653A (zh) * | 2016-06-06 | 2016-11-09 | 江苏天和制药有限公司 | 奥美普林中间体肉桂腈的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2628236A (en) * | 1953-02-10 | S-benzyl | ||
| US3049544A (en) * | 1962-08-14 | Method for the preparation of | ||
| US2658897A (en) * | 1951-06-27 | 1953-11-10 | Burroughs Wellcome Co | 2, 4-diamino-5-benzyl pyrimidines |
| GB734801A (en) * | 1953-03-06 | 1955-08-10 | Wellcome Found | Improvements in and relating to derivatives of pyrimidine and the manufacture thereof |
| US2783178A (en) * | 1954-06-22 | 1957-02-26 | American Scient Lab Inc | Stable concentrated sulfaquinoxaline solutions and method for preparing |
| US2823160A (en) * | 1955-03-29 | 1958-02-11 | Whitmoyer Lab Inc | Substituted pyrimidines compositions for chemotherapy of coccidiosis |
| US2909522A (en) * | 1957-02-21 | 1959-10-20 | Burroughs Wellcome Co | Trialkoxybenzylpyrimidines and method |
| DE1303727B (de) * | 1959-09-03 | 1976-02-05 | Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London | Alpha-Arylidensubstituierte Propioni-Irile |
| US3085937A (en) * | 1960-11-21 | 1963-04-16 | Shionogi & Co | Method of combating coccidiosis with sulfonamide compositions |
| US3485840A (en) * | 1964-11-12 | 1969-12-23 | Hoffmann La Roche | 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes |
-
1965
- 1965-05-07 US US454172A patent/US3485840A/en not_active Expired - Lifetime
- 1965-06-02 US US460834A patent/US3461206A/en not_active Expired - Lifetime
- 1965-07-09 US US470917A patent/US3341541A/en not_active Expired - Lifetime
- 1965-10-15 CH CH1427165A patent/CH467784A/de unknown
- 1965-10-20 DE DE19651545966 patent/DE1545966A1/de active Pending
- 1965-10-21 IL IL24497A patent/IL24497A/en unknown
- 1965-10-21 IL IL24498A patent/IL24498A/xx unknown
- 1965-10-22 CH CH1464865A patent/CH467270A/de unknown
- 1965-10-25 DE DE1545967A patent/DE1545967C3/de not_active Expired
- 1965-10-27 IL IL24534A patent/IL24534A/xx unknown
- 1965-10-27 IL IL6532695A patent/IL32695A/xx unknown
- 1965-10-27 IL IL32694A patent/IL32694A/xx unknown
- 1965-10-27 IL IL32697A patent/IL32697A/xx unknown
- 1965-10-27 IL IL6532696A patent/IL32696A/en unknown
- 1965-10-28 DK DK554065AA patent/DK125553B/da unknown
- 1965-10-30 FR FR36822A patent/FR5411M/fr not_active Expired
- 1965-11-01 FI FI2606/65A patent/FI43251B/fi active
- 1965-11-02 NL NL6514178A patent/NL6514178A/xx unknown
- 1965-11-05 GB GB58792/67A patent/GB1132084A/en not_active Expired
- 1965-11-05 GB GB58793/67A patent/GB1132085A/en not_active Expired
- 1965-11-05 GB GB58794/67A patent/GB1132086A/en not_active Expired
- 1965-11-05 GB GB46935/65A patent/GB1132082A/en not_active Expired
- 1965-11-05 GB GB46936/65A patent/GB1133766A/en not_active Expired
- 1965-11-05 GB GB58791/67A patent/GB1132083A/en not_active Expired
- 1965-11-05 GB GB46937/65A patent/GB1062508A/en not_active Expired
- 1965-11-08 BE BE671981D patent/BE671981A/xx unknown
- 1965-11-08 BE BE671982D patent/BE671982A/xx unknown
- 1965-11-08 BE BE671983D patent/BE671983A/xx not_active IP Right Cessation
- 1965-11-08 NL NL6514472A patent/NL6514472A/xx unknown
- 1965-11-09 BR BR174670/65A patent/BR6574670D0/pt unknown
- 1965-11-09 BR BR174668/65A patent/BR6574668D0/pt unknown
- 1965-11-09 BR BR174667/65A patent/BR6574667D0/pt unknown
- 1965-11-11 NO NO160436A patent/NO119948B/no unknown
- 1965-11-11 NO NO160437A patent/NO115741B/no unknown
- 1965-11-11 DK DK581065AA patent/DK115847B/da unknown
- 1965-11-12 IT IT25233/65A patent/IT1058251B/it active
- 1965-11-12 SE SE14670/65A patent/SE326185B/xx unknown
- 1965-11-12 SE SE14669/65A patent/SE327122B/xx unknown
- 1965-11-12 NL NL6514743.A patent/NL163213C/xx not_active IP Right Cessation
- 1965-11-12 SE SE3420/69A patent/SE346314B/xx unknown
- 1965-11-12 SE SE14668/65A patent/SE311160B/xx unknown
-
1967
- 1967-12-31 MY MY1967159A patent/MY6700159A/xx unknown
-
1972
- 1972-12-30 MY MY71/72A patent/MY7200071A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO119948B (pl) | ||
| US3502673A (en) | Aryl-pyrimidine-alkanoic acid derivatives | |
| CA2056808A1 (en) | Hydroxyquinolone derivatives | |
| Beaman | New syntheses of purine | |
| NO160436B (no) | Analogifremgangsmaate til fremstilling av farmasoeytisk anvendbare substituerte benzofenoner. | |
| SU1240363A3 (ru) | Способ получени ( @ )-5-(2-бромвинил)уридина | |
| EP0055068B1 (en) | Quinolone derivatives and their use as pharmaceuticals | |
| US3341548A (en) | Nitroimidazoles and their preparation | |
| IL27364A (en) | Iminopyrimidines and process for their preparation | |
| US3007927A (en) | Triazine derivatives | |
| Clapp et al. | Studies in the Quinoline Series. III. Some Derivatives of 4-Styrylquinoline1 | |
| US2906757A (en) | Their preparation | |
| US3923792A (en) | Sulfacytosine derivatives | |
| JPS6139288B2 (pl) | ||
| Johnson et al. | Researches on Pyrimidines. CLIX. Synthesis of 6-Benzyl-and 5-Benzyluracils1 | |
| US3481932A (en) | 2-anilino-5-methyl-6-phenylpyrimidines and congeners | |
| US2731465A (en) | 5-halo-6-amino-uracils and derivatives thereof | |
| US3441560A (en) | Cyclopropyl-2-sulphanilamido-pyrimidines | |
| US3507958A (en) | Compositions and methods of treating bacteria with cyclopropyl-2-sulphanilamido-pyrimidines | |
| GERSHON et al. | Pyrimidines. I. Some halogenated monomethylpyrimidines | |
| PL89093B1 (pl) | ||
| US3281408A (en) | 1-(2-amino-4-azido-6-phenyl-5-pyrimidinyl)-2-propanone semicarbazone and congeners | |
| NO161102B (no) | Lokkemat for gnagere omfattende foede og en gift. | |
| US2807616A (en) | Oxazolopyrimidines and method of preparing same | |
| US4129654A (en) | Isoxazolo[3,4-d]pyrimidines useful as antiinflammatory-analgesic agents |